Home/Torqur/Christoph Tschumi
CT

Christoph Tschumi

Non-Executive Board Member

Torqur

Therapeutic Areas

Torqur Pipeline

DrugIndicationPhase
Bimiralisib (PQR309)Actinic KeratosisPhase 2
Next-gen PI3K/mTOR inhibitorsOncologyPre-clinical